D-33
Active substance: ATROPA BELLADONNA, BUFO BUFO CUTANEOUS GLAND, COPPER, ANEMONE PRATENSIS, SILICON DIOXIDE, ZINC
SOLUTION · ATROPA BELLADONNA 30 [hp_X]/mL, BUFO BUFO CUTANEOUS GLAND 200 [hp_X]/mL, COPPER 12 [hp_X]/mL, ANEMONE PRATENSIS 30 [hp_X]/mL, SILICON DIOXIDE 30 [hp_X]/mL, ZINC 12 [hp_X]/mL
United StatesActive
Marketing holder: DNA Labs, Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- ATROPA BELLADONNA · 30 [hp_X]/mL
- BUFO BUFO CUTANEOUS GLAND · 200 [hp_X]/mL
- COPPER · 12 [hp_X]/mL
- ANEMONE PRATENSIS · 30 [hp_X]/mL
- SILICON DIOXIDE · 30 [hp_X]/mL
- ZINC · 12 [hp_X]/mL
Registration
- Registration number
- 58264-0033
- Registration status
- Active
- Dispensing
- Over the counter
- Route
- SUBLINGUAL
Sources
- product · openFDA NDC · 58264-0033 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 58264-0033 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 58264-0033 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 58264-0033 · Verified 2026-10-09 · open in source
- ingredients.2 · openFDA NDC · 58264-0033 · Verified 2026-10-09 · open in source
- ingredients.3 · openFDA NDC · 58264-0033 · Verified 2026-10-09 · open in source
- ingredients.4 · openFDA NDC · 58264-0033 · Verified 2026-10-09 · open in source
- ingredients.5 · openFDA NDC · 58264-0033 · Verified 2026-10-09 · open in source